Skip to main content

Healthcare

Making A Meaningful Impact In The Lives Of Those Suffering From Rare Diseases

Published

Feb 28, 2022

Catalyst Pharmaceuticals Co-Founder & CEO Patrick McEnany joins Jill Malandrino on Nasdaq TradeTalks to discuss making a meaningful impact in the lives of those suffering from rare diseases.

No transcript available

More in this Series

See all

My Quotes
My European Quotes
Watchlist

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.

/

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Shares, Indexes, ETP and more asset classes.

/

Edit Watchlist

Your Watchlist is empty.

Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.

/